These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 2996919

  • 1. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL, Barrett-Connor E.
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 5. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hormone substitution in the menopause: effect on lipids and cardiovascular risk].
    Keller U.
    Schweiz Rundsch Med Prax; 1991 Apr 16; 80(16):413-7. PubMed ID: 2038637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arteriosclerosis risk. The roles of oral contraceptives and postmenopausal estrogens.
    Knopp RH.
    J Reprod Med; 1986 Sep 16; 31(9 Suppl):913-21. PubMed ID: 3772911
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar 16; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Mar 16; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Estrogen therapy for the climateric and thromboembolic risk].
    Campagnoli C, Prelato L, Rossetti MG.
    Minerva Ginecol; 1980 May 16; 32(5):429-35. PubMed ID: 7393492
    [Abstract] [Full Text] [Related]

  • 16. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG.
    J Reprod Med; 1984 Jul 16; 29(7 Suppl):539-46. PubMed ID: 6481707
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM, Leonardo F, Ricci S, Serra GB, Chierchia SL.
    Ann Ist Super Sanita; 1997 Jul 16; 33(2):199-202. PubMed ID: 9470240
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH.
    Arch Intern Med; 1997 Jul 16; 156(15):1693-700. PubMed ID: 8694668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.